Alireza Heidari, Margaret Hotz, Nancy MacDonald, Victoria Peterson, Angela Caissutti, E. Besana, J. Esposito, K. Schmitt, Ling-Yu Chan, Francesca Sherwood, M. Henderson, Jimmy Kimmel
{"title":"主动靶向氧化铼(ReO2)、三氧化铼(ReO3)和氧化铼(Re2O7)纳米粒子作为癌症治疗药物在同步加速器和同步回旋加速器辐射下膨胀杀死癌细胞","authors":"Alireza Heidari, Margaret Hotz, Nancy MacDonald, Victoria Peterson, Angela Caissutti, E. Besana, J. Esposito, K. Schmitt, Ling-Yu Chan, Francesca Sherwood, M. Henderson, Jimmy Kimmel","doi":"10.14419/ijac.v9i2.31656","DOIUrl":null,"url":null,"abstract":"In the current research, active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations is investigated. The calculation of thickness and optical constants of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations produced using sol–gel method over glassy medium through a single reflection spectrum is presented. To obtain an appropriate fit for reflection spectrum, the classic Drude–Lorentz model for parametric di–electric function is used. The best fitting parameters are determined to simulate the reflection spectrum using Lovenberg–Marquardt optimization method. The simulated reflectivity from the derived optical constants and thickness are in good agreement with experimental results. Active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations. ","PeriodicalId":13723,"journal":{"name":"International Journal of Advanced Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Active targeting of rhenium (iv) oxide (ReO2), rhenium trioxide (ReO3) and rhenium (vii) oxide (Re2O7) nanoparticles as cancer therapeutics swell-up to kill cancer cells under synchrotron and synchrocyclotron radiations\",\"authors\":\"Alireza Heidari, Margaret Hotz, Nancy MacDonald, Victoria Peterson, Angela Caissutti, E. Besana, J. Esposito, K. Schmitt, Ling-Yu Chan, Francesca Sherwood, M. Henderson, Jimmy Kimmel\",\"doi\":\"10.14419/ijac.v9i2.31656\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the current research, active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations is investigated. The calculation of thickness and optical constants of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations produced using sol–gel method over glassy medium through a single reflection spectrum is presented. To obtain an appropriate fit for reflection spectrum, the classic Drude–Lorentz model for parametric di–electric function is used. The best fitting parameters are determined to simulate the reflection spectrum using Lovenberg–Marquardt optimization method. The simulated reflectivity from the derived optical constants and thickness are in good agreement with experimental results. Active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations. \",\"PeriodicalId\":13723,\"journal\":{\"name\":\"International Journal of Advanced Chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Advanced Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14419/ijac.v9i2.31656\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Advanced Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14419/ijac.v9i2.31656","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Active targeting of rhenium (iv) oxide (ReO2), rhenium trioxide (ReO3) and rhenium (vii) oxide (Re2O7) nanoparticles as cancer therapeutics swell-up to kill cancer cells under synchrotron and synchrocyclotron radiations
In the current research, active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations is investigated. The calculation of thickness and optical constants of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations produced using sol–gel method over glassy medium through a single reflection spectrum is presented. To obtain an appropriate fit for reflection spectrum, the classic Drude–Lorentz model for parametric di–electric function is used. The best fitting parameters are determined to simulate the reflection spectrum using Lovenberg–Marquardt optimization method. The simulated reflectivity from the derived optical constants and thickness are in good agreement with experimental results. Active targeting of Rhenium (IV) Oxide (ReO2), Rhenium Trioxide (ReO3) and Rhenium (VII) Oxide (Re2O7) nanoparticles as cancer therapeutics swell–up to kill cancer cells under synchrotron and synchrocyclotron radiations.